Fenoff, R. S., & Wilson, J. M. (2011). Counterfeit pharmaceuticals: examining the multidimensional risks to African nations. In L. Kennedy & E. F. McGarrell (Eds.), Crime and Terrorism Risk (pp. 227-241). New York: Routledge. https://www.routledge.com/Crime-and-Terrorism-Risk-Studies-in-Criminology-and-Criminal-Justice/Kennedy-McGarrell/p/book/9780415991827
Randhawa, P., Calantone, R. J., & Voorhees, C. M. (2015). The pursuit of counterfeited luxury: an examination of the negative side effects of close consumer–brand connections. Journal of Business Research. doi:10.1016/j.jbusres.2015.02.022 https://www.sciencedirect.com/science/article/pii/S0148296315001046 Over the past two decades, the counterfeiting industry has cost U.S. manufacturers over $200 billion. In this study, we extend current research on …
Kennedy, J. P., Haberman, C. P., & Wilson, J. M. (2018). Occupational pharmaceutical counterfeiting: a crime scripts analysis. Victims & Offenders, 13(2), 196-214. doi:10.1080/15564886.2016.1217961 https://www.tandfonline.com/doi/abs/10.1080/15564886.2016.1217961 This article presents a crime script for pharmaceutical counterfeiting schemes perpetrated by licensed health care professionals; we term these types of schemes occupational pharmaceutical counterfeiting. To date, there have been no …
Occupational pharmaceutical counterfeiting: a crime scripts analysis Read More »
Mace, R. R. (2009). A case study of melamine as a counterfeit food product additive in Chinese human and animal food supply chain networks. The global counterfeit food market is estimated at approximately US $49 billion. European Union Customs reported a 200% increase in food-related counterfeit seizures over the past several years, and the UK’s Food Standards …
Fenoff, R. S., & Wilson, J. M. (2009). Africa’s counterfeit pharmaceutical epidemic: the road ahead. Widespread infectious diseases coupled with pervasive poverty make the developing countries on the African continent particularly vulnerable to harm from counterfeit drugs, which now constitute more than 30 percent of all medicines sold in Africa, including up to 70 percent of drugs sold in …
Africa’s counterfeit pharmaceutical epidemic: the road ahead Read More »
Trent, C., & Moyer, D. C. (2013). Assessing the risks of counterfeiting and illicit diversion for health care products. Counterfeiting and illicit diversion are problems that affect a wide variety of industries on a global basis. A counterfeit is a product designed, dressed, branded, and/or packaged in a manner intended to be indistinguishable from that of …
Assessing the risks of counterfeiting and illicit diversion for health care products Read More »
Heinonen, J. A., & Wilson, J. M. (2011). Pharmaceutical counterfeiting in the US: differentiating dimensions of the risk. The creation of a product counterfeiting database highlights variation in known incidents of counterfeit pharmaceuticals across several important dimensions. By understanding how these incidents differ, researchers can provide empirical insights into the problem, develop evidence-based anti-counterfeit strategy and promote awareness …
Pharmaceutical counterfeiting in the US: differentiating dimensions of the risk Read More »
Wilson, J. M., & Fenoff, R. (2011). The health and economic effects of counterfeit pharmaceuticals in Africa. Pharmaceutical counterfeiting in Africa remains a serious threat to quality health care and the African economy. An impairment to public health, counterfeit pharmaceuticals used to combat malaria and tuberculosis have been blamed for up to 700,000 deaths in Africa each year. …
The health and economic effects of counterfeit pharmaceuticals in Africa Read More »
